Этот веб-сайт требует, чтобы для Вашего браузера был включен JavaScript.
Пожалуйста, включите JavaScript и перезагрузите страницу.
Для веб-сайта требуется, чтобы Ваш браузер разрешил использование файлов cookie для входа в систему.
Пожалуйста, активируйте cookies и перезагрузите страницу.
Carte romana
Carte rusa
Carte engleza
Vezi toate cartile
Top branduri cosmetica
Cosmetica Coreeana
Machiaj
Ingrijire ten
Ingrijire par
Ingrijire corp
Produse de baie
Igiena orala
Igiena intima
Igiena sexuala
Cosmetice barbati
Seturi cadou
Naturale si organice
Vezi toate cosmeticele
Top branduri dermatocosmetica
Protectie solara
Seturi cadou si pachete promo
Parfumuri pentru femei
Top branduri femei
Premium brands femei
Parfumuri unisex
Vezi toate parfumurile
Parfumuri pentru barbati
Top branduri barbati
Premium brands barbati
Jucarii si jocuri
Hrana si articole copii
Scutece si servetele
Rechizite si papetarie
Vezi toate produsele
Nutritie & Suplimente
Branduri
Certificate Cadou
Felicitari
Plicuri
Cutii si Accesorii
Marco ColizziCannabis: Neuropsychiatry and Its Effects on Brain and Behavior, Hardcover
в Пункте приема от 99,9 лей
Даже распечатанный
Перед оплатой
Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In regular users, the development of tolerance to some of the effects of cannabis, especially the pleasurable ones, may lead to progressively heavier use in order to obtain the same effects in terms of their intensity, with higher health risks. However, the Cannabis Sativa plant contains different chemicals with different potential effects. In this regard, cannabidiol has gained interest because of its potential therapeutic properties, in line with evidence that CBD and Δ9-THC may exhibit opposite effects at the cannabinoid receptor type 1 (CB1), Δ9-THC being a partial agonist and CBD an antagonist/inverse agonist. Different cannabinoids may modulate human brain function and behavior in different ways, with different risk-benefit profiles.
Мы хотели бы узнать Ваше мнение! Оценить и пересмотреть этот пункт
Нет ни одного отзыва от других пользователей.